Search results

This quality standard covers care for adults (aged 18 and over) who are malnourished or at risk of malnutrition in hospital or in the community. It includes identifying people at risk of malnutrition and providing nutrition support, including dietary changes and artificial nutrition support given through feeding tubes (enteral nutrition) or directly into a vein (parenteral nutrition). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

30 November 2012

Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.

Result type

Technology appraisal guidance

Published

14 December 2022

Evidence-based recommendations on minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac pain in adults. This involves fixing the sacrum to the ilium using 2 or 3 metal implants.

Result type

HealthTech guidance

Published

5 April 2017

Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

Result type

Evidence summary

Published

9 June 2016

Evidence-based recommendations on nintedanib for treating progressive fibrosing interstitial lung diseases in adults.

Result type

Technology appraisal guidance

Published

17 November 2021

Referral points to virtual wards are similar to traditional models of care. Our guidance and advice can help you decide where to provide care and what to consider.

This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis. It aims to improve the physical and mental health and quality of life of people with faecal incontinence.

Result type

Clinical guideline

Published

27 June 2007

Evidence-based recommendations on risankizumab (Skyrizi) for treating active psoriatic arthritis in adults.

Result type

Technology appraisal guidance

Published

13 July 2022

Summary of the evidence on eculizumab to prevent the recurrence of C3 glomerulopathy post-transplant to inform local NHS planning and decision-making

Result type

Evidence summary

Published

26 June 2015

Evidence-based recommendations on pegcetacoplan (Aspaveli) for treating paroxysmal nocturnal haemoglobinuria in adults who have anaemia after at least 3 months of treatment with a C5 inhibitor.

Result type

Technology appraisal guidance

Published

9 March 2022

Evidence-based recommendations on guselkumab (Tremfya) for active psoriatic arthritis after inadequate response to DMARDs in adults.

Result type

Technology appraisal guidance

Published

10 August 2022

Evidence-based recommendations on photorefractive (laser) surgery for the correction of refractive errors. This involves using a special laser to permanently change the shape of the cornea.

Result type

HealthTech guidance

Published

22 March 2006

Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for previously treated metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease.

Result type

Technology appraisal guidance

Published

25 May 2011

Summary of the evidence on lurasidone (Latuda) for schizophrenia in adults aged 18 and over to inform local NHS planning and decision-making

Result type

Evidence summary

Published

23 September 2014